Manuel Hidalgo Medina

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Álvaro Arjona‐Sánchez, P. Barrios, Emrique Boldo-Roda et al. · BMC Cancer · 2018 · 96 citations · Full text

Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Cancer Research · 2014 · 76 citations

Pathology, Selective Pan-fgfr Inhibitor, Advanced Solid Tumors +19

Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 2014 · 37 citations

Medicine, Advanced Solid Tumors, Cancer Biology +7

The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer

Paula Moreno, Maribel Lara‐Chica, Rafael Soler-Torronteras et al. · PLoS ONE · 2015 · 22 citations · Full text